These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33098486)

  • 1. SOX2/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma.
    Forghanifard MM; Kasebi P; Abbaszadegan MR
    Mol Cell Biochem; 2021 Feb; 476(2):921-929. PubMed ID: 33098486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MEIS1 promotes expression of stem cell markers in esophageal squamous cell carcinoma.
    Zargari S; Negahban Khameneh S; Rad A; Forghanifard MM
    BMC Cancer; 2020 Aug; 20(1):789. PubMed ID: 32819319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NOTCH and Esophageal Squamous Cell Carcinoma.
    Li Y; Li Y; Chen X
    Adv Exp Med Biol; 2021; 1287():59-68. PubMed ID: 33034026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High expression of the stemness-associated molecule Nanog in esophageal squamous cell carcinoma tissues promotes tumor invasion and metastasis by activating the TGF-β signaling pathway].
    Sun C; Zheng S; Li M; Yang M; Qin M; Xu Y; Liang W; Hu J; Wang L; Li F; Zhou H; Yang L
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jun; 44(6):1209-1216. PubMed ID: 38977352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSK3β-driven SOX2 overexpression is a targetable vulnerability in esophageal squamous cell carcinoma.
    Kang L; Liu Y; He J; Wang Y; Xue M; Wu X; Wang Z; Zhang Y; Chu M; Li J; Wei W; Li J; Li E; Liao L; Xiao J; Zhang R; Xu L; Wong J
    Oncogene; 2023 Jul; 42(30):2297-2314. PubMed ID: 37349645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activin and Hepatocyte Growth Factor Promotes Colorectal Cancer Stemness and Metastasis through FOXM1/SOX2/CXCR4 Signaling.
    Peng H; Ye T; Deng L; Yang X; Li Q; Tong J; Guo J
    Gut Liver; 2024 May; 18(3):476-488. PubMed ID: 37458065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal Squamous Cell Carcinoma Is Accompanied by Local and Systemic Changes in L-arginine/NO Pathway.
    Bednarz-Misa I; Fortuna P; Fleszar MG; Lewandowski Ł; Diakowska D; Rosińczuk J; Krzystek-Korpacka M
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gelatin-based 3D biomimetic scaffolds platform potentiates culture of cancer stem cells in esophageal squamous cell carcinoma.
    Wu Y; Liang H; Luo A; Li Y; Liu Z; Li X; Li W; Liang K; Li J; Liu Z; Du Y
    Biomaterials; 2023 Nov; 302():122323. PubMed ID: 37717405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic analyses reveal FAM84B and the NOTCH pathway are associated with the progression of esophageal squamous cell carcinoma.
    Cheng C; Cui H; Zhang L; Jia Z; Song B; Wang F; Li Y; Liu J; Kong P; Shi R; Bi Y; Yang B; Wang J; Zhao Z; Zhang Y; Hu X; Yang J; He C; Zhao Z; Wang J; Xi Y; Xu E; Li G; Guo S; Chen Y; Yang X; Chen X; Liang J; Guo J; Cheng X; Wang C; Zhan Q; Cui Y
    Gigascience; 2016; 5():1. PubMed ID: 26759717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arsenic promotes the COX2/PGE2-SOX2 axis to increase the malignant stemness properties of urothelial cells.
    Ooki A; Begum A; Marchionni L; VandenBussche CJ; Mao S; Kates M; Hoque MO
    Int J Cancer; 2018 Jul; 143(1):113-126. PubMed ID: 29396848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bismuth Sulfide Nanoflowers Facilitated miR339 Delivery to Overcome Stemness and Radioresistance through Ubiquitin-Specific Peptidase 8 in Esophageal Cancer.
    Zhou X; Gao F; Gao W; Wang Q; Li X; Li X; Li W; Liu J; Zhou H; Luo A; Chen C; Liu Z
    ACS Nano; 2024 Jul; 18(29):19232-19246. PubMed ID: 38996055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The SOX2/PDIA6 axis mediates aerobic glycolysis to promote stemness in non-small cell lung cancer cells.
    Wan X; Ma D; Song G; Tang L; Jiang X; Tian Y; Yi Z; Jiang C; Jin Y; Hu A; Bai Y
    J Bioenerg Biomembr; 2024 Jun; 56(3):323-332. PubMed ID: 38441855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SALL4 - KHDRBS3 network enhances stemness by modulating CD44 splicing in basal-like breast cancer.
    Matsumoto Y; Itou J; Sato F; Toi M
    Cancer Med; 2018 Feb; 7(2):454-462. PubMed ID: 29356399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jag1/2 maintain esophageal homeostasis and suppress foregut tumorigenesis by restricting the basal progenitor cell pool.
    Huang H; Jiang Y; Liu J; Luo D; Yuan J; Mu R; Yu X; Sun D; Lin J; Chen Q; Li X; Jiang M; Xu J; Chu B; Yin C; Zhang L; Ye Y; Cao B; Wang Q; Zhang Y
    Nat Commun; 2024 May; 15(1):4124. PubMed ID: 38750026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FPR3 reprograms glycolytic metabolism and stemness in gastric cancer via calcium-NFATc1 pathway.
    Wang L; Mao X; Yu X; Su J; Li Z; Chen Z; Ren Y; Huang H; Wang W; Zhao C; Hu Y
    Cancer Lett; 2024 Jul; 593():216841. PubMed ID: 38614385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CDK7-YAP-LDHD axis promotes D-lactate elimination and ferroptosis defense to support cancer stem cell-like properties.
    Lv M; Gong Y; Liu X; Wang Y; Wu Q; Chen J; Min Q; Zhao D; Li X; Chen D; Yang D; Yeerken D; Liu R; Li J; Zhang W; Zhan Q
    Signal Transduct Target Ther; 2023 Aug; 8(1):302. PubMed ID: 37582812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential sequences and single nucleotide polymorphism of exosomal SOX2 DNA in cancer.
    Vaidya M; Sugaya K
    PLoS One; 2020; 15(2):e0229309. PubMed ID: 32092088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SOX2 protein biochemistry in stemness, reprogramming, and cancer: the PI3K/AKT/SOX2 axis and beyond.
    Schaefer T; Lengerke C
    Oncogene; 2020 Jan; 39(2):278-292. PubMed ID: 31477842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOX2 and PI3K Cooperate to Induce and Stabilize a Squamous-Committed Stem Cell Injury State during Lung Squamous Cell Carcinoma Pathogenesis.
    Kim BR; Van de Laar E; Cabanero M; Tarumi S; Hasenoeder S; Wang D; Virtanen C; Suzuki T; Bandarchi B; Sakashita S; Pham NA; Lee S; Keshavjee S; Waddell TK; Tsao MS; Moghal N
    PLoS Biol; 2016 Nov; 14(11):e1002581. PubMed ID: 27880766
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Requirement of the transcription factor YB-1 for maintaining the stemness of cancer stem cells and reverting differentiated cancer cells into cancer stem cells.
    Yang F; Cui P; Lu Y; Zhang X
    Stem Cell Res Ther; 2019 Aug; 10(1):233. PubMed ID: 31375149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.